Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors
暂无分享,去创建一个
G. Melloni | M. Colonna | M. Mattioli | M. Cella | C. Doglioni | C. Battaglia | K. Steffensen | T. Jakobsson | D. Maggioni | R. Fontana | Laura Raccosta | V. Russo | G. Mangili | A. Bergamini | R. Crocchiolo | A. Paniccia | A. Bandiera | L. Rovati | Tomas Jakobsson
[1] M. Karin,et al. NF-κB, inflammation, immunity and cancer: coming of age , 2018, Nature Reviews Immunology.
[2] P. Krebs,et al. TREM-1 promotes intestinal tumorigenesis , 2017, Scientific Reports.
[3] M. Dessing,et al. TREM‐1 and its potential ligands in non‐infectious diseases: from biology to clinical perspectives , 2017, Pharmacology & therapeutics.
[4] Y. Saeys,et al. TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine , 2017, Nature Communications.
[5] T. Yun,et al. The Importance of Dendritic Cells in Maintaining Immune Tolerance , 2017, The Journal of Immunology.
[6] A. Saghatelian,et al. SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism. , 2017, Cell metabolism.
[7] A. Valledor,et al. The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD Metabolism. , 2017, Cell reports.
[8] R. Förster,et al. Dendritic cell migration in health and disease , 2016, Nature Reviews Immunology.
[9] J. Austyn. Dendritic Cells in the Immune System-History, Lineages, Tissues, Tolerance, and Immunity. , 2016, Microbiology spectrum.
[10] C. Simillion,et al. TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis , 2016, Nature Communications.
[11] C. Doglioni,et al. The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice , 2016, Cancer Immunology, Immunotherapy.
[12] E. Gratton,et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling , 2015, eLife.
[13] D. Agrawal,et al. Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells , 2015, Expert review of clinical immunology.
[14] John Vu,et al. Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity , 2015, eLife.
[15] B. Pulendran. The varieties of immunological experience: of pathogens, stress, and dendritic cells. , 2015, Annual review of immunology.
[16] Jeffrey L. Dantzler,et al. Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1 , 2015, The Journal of Immunology.
[17] D. Maggioni,et al. Cholesterol metabolites and tumor microenvironment: the road towards clinical translation , 2015, Cancer Immunology, Immunotherapy.
[18] Chirayu Pankaj Goswami,et al. PROGgeneV2: enhancements on the existing database , 2014, BMC Cancer.
[19] R. Evans,et al. Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.
[20] S. A. van de Pavert,et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity , 2014, Nature.
[21] Renato Ostuni,et al. Lineages, cell types and functional states: a genomic view. , 2013, Current opinion in cell biology.
[22] Guang-xiu Lu,et al. TREM-1 inhibition attenuates inflammation and tumor within the colon. , 2013, International immunopharmacology.
[23] J. Gustafsson,et al. The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils , 2013, The Journal of experimental medicine.
[24] Y. Lee,et al. Regulation of TREM-1 expression by 1,25-dihydroxyvitamin D3 in human monocytes/macrophages. , 2013, Immunology letters.
[25] V. Soumelis,et al. Human inflammatory dendritic cells induce Th17 cell differentiation. , 2013, Immunity.
[26] E. Villablanca. Retinoic acid-producing DCs and gut-tropic FOXP3+ regulatory T cells in the induction of oral tolerance , 2013, Oncoimmunology.
[27] G. Trinchieri,et al. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. , 2012, Cancer Research.
[28] S. Qiu,et al. Expression of TREM‐1 in hepatic stellate cells and prognostic value in hepatitis B‐related hepatocellular carcinoma , 2012, Cancer science.
[29] S. Heikkinen,et al. Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages , 2012, BMC Genomics.
[30] H. Weiner,et al. Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice. , 2011, Gastroenterology.
[31] Y. Belkaid,et al. The role of retinoic acid in tolerance and immunity. , 2011, Immunity.
[32] F. Novelli,et al. Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. , 2011, Blood.
[33] E. Devilard,et al. Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. , 2010, Blood.
[34] Sandro Sonnino,et al. Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses , 2010, Nature Medicine.
[35] Peter Tontonoz,et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. , 2009, Immunity.
[36] M. Rescigno,et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells , 2009, Gut.
[37] Jing Chen,et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..
[38] J. Gustafsson,et al. GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. , 2009, Molecular cell.
[39] L. Nagy,et al. 1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype12 , 2009, The Journal of Immunology.
[40] Peter Tontonoz,et al. Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.
[41] Hsuan-Yu Chen,et al. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. , 2008, American journal of respiratory and critical care medicine.
[42] M. Colonna,et al. Uncovering the TREM-1-TLR connection. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[43] F. Seibold,et al. TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. , 2007, The Journal of clinical investigation.
[44] T. Willson,et al. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. , 2007, Molecular cell.
[45] L. Adorini,et al. 1,25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells1 , 2007, The Journal of Immunology.
[46] M. Colonna,et al. The TREM receptor family and signal integration , 2006, Nature Immunology.
[47] M. Colonna,et al. Macrophages Expressing Triggering Receptor Expressed on Myeloid Cells-1 Are Underrepresented in the Human Intestine1 , 2005, The Journal of Immunology.
[48] Peter Tontonoz,et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors , 2003, Nature Medicine.
[49] M. Colonna,et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.
[50] M. Colonna,et al. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.
[51] D. Peet,et al. The LXRs: a new class of oxysterol receptors. , 1998, Current opinion in genetics & development.